ANDA 210012, held by Zydus Pharms. Nifedipine.
As of Nov 16, 2026, ANDA 210012 (Nifedipine), held by Zydus Pharms, was first approved by FDA on Dec 19, 2017, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 19, 2017 | Original application | Approved | None posted |
| Nifedipine30MG · tablet, extended release;oral | Nifedipine | Rx |
| Nifedipine60MG · tablet, extended release;oral | Nifedipine | Rx |
| Nifedipine90MG · tablet, extended release;oral | Nifedipine | Rx |
| Aug 11, 2022 | Supplement 3Labeling · Standard review | Approved | None posted |
| Dec 19, 2017 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters